The results revealed that CPEB2 downregulation in anti-miR-210-3p-treated HepG2 cells promoted HCC migration and invasion in the cell migration and invasion assays (Figure 6C,D). This evidence concerns the gene CPEB2 and hepatocellular carcinoma.